Instagram banned Robert F. Kennedy Jr. from the platform Wednesday for criticizing the COVID-19 vaccine, according to The Hill.
Instagram removed the account after Kennedy questioned Bill Gates for his support of vaccinations, according to Fox Business.
“We removed this account for repeatedly sharing debunked claims about the coronavirus or vaccines,” a spokesperson for Facebook said in a statement. Facebook, which owns Instagram, and Twitter had not removed Kennedy as of Thursday, reported The Hill.
Kennedy has advocated for states to exempt parents from vaccinating their children and has linked vaccines to several deaths and called it a cause of autism, according to CNN. The Center for Countering Digital Hate, a nonprofit organization, named Kennedy as one of the most significant figures to spread misinformation regarding COVID-19.
Dangerous anti-vaxxer Robert F. Kennedy Jr. has been banned from Instagram. https://t.co/x3abPCxpLd
— Kyle Griffin (@kylegriffin1) February 11, 2021
Kennedy is the chair of the Children’s Health Defense, a nonprofit concerned with the effects of vaccinations. The organization had funded more than half of Facebook’s anti-vaccine advertisements, according to The New York Times.
He reportedly blamed baseball star Hank Aaron’s death on the COVID-19 vaccine which he received in Atlanta on Jan 5., according The New York Times.
The Children’s Health Defense told CNN that they could not comment on Instagram’s decision.
Facebook has increased efforts to remove anti-vaccination posts saying on Monday that pages and accounts are “subject to removal,” The Hill reported. They will additionally make it difficult to search accounts on Instagram that discourage people from getting vaccinated, according to CNN.
Members of his family have criticized Kennedy for his vaccine misinformation. Two of his siblings and his niece wrote in a column for Politico that he was spreading “dangerous misinformation.”
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected]